Delayed allergic reactions to omalizumab: are patients reporting all cases?
Barry
Peter J
PJ
O'Mahony
Ann
A
Finnegan
Collette
C
O'Connor
Terence M
TM
D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000707:Anaphylaxis / Q000139:chemically induced*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069444:Omalizumab; D013997:Time Factors
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab